Evaluating whether Lexeo Therapeutics (NASDAQ: LXEO) stock is a buy, sell, or hold requires examining consensus ratings compiled from Wall Street equity research analysts covering the biotechnology sector. Because stock recommendations shift dynamically based on clinical trial milestones, upcoming regulatory catalysts, and macroeconomic biotech financing trends, investors should consult up-to-date brokerage reports and professional financial guidance before trading.